Categories

Category: Jessica DaMassa

Health in 2 Point 00 Episode 89 | IPOs, Oscar and Fitbit

Today on Health in 2 Point 00, it’s IPO day! On Episode 89, Jess asks me about the recent IPOs, Oscar Health getting into Medicare Advantage, and Fitbit accuracy in people of color. Jess asks me to weigh in on whether Livongo’s IPO was better than we expected and it’s safe to say that they are growing fast. On the flip side, the “silent” IPO that no one seems to be talking about is Health Catalyst, which is also doing quite well with a $1.6 billion valuation although they are not growing as fast as Livongo is. Next, Oscar Health decided to enter into Medicare Advantage, which is not surprising because that’s where the real money is in the insurance side. Finally, Fitbits and other wearables may not be tracking heart rates accurately in people of color, so what does this mean for the wearables industry—and their potential use for medical purposes? —Matthew Holt

What’s After Health 2.0? Trends Shaping Health Tech | Indu Subaiya, Health 2.0 & Catalyst Health

By JESSICA DAMASSA, WTF HEALTH

“Renaissance woman” and Catalyst Health President & Senior Advisor for HIMSS, Indu Subaiya, has spent the past 13 years tracking the growth and integration of digital health and health technology into healthcare systems worldwide. So, how have things evolved over time? What’s new and changing? Indu points out some of the differences she’s seeing in the European approach to healthcare’s ‘digital transformation’ (hint: they’re winning at clinician engagement) and explains what startups around the world should be focused on to remain relevant as Big Tech companies infiltrate the space.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Helping Health Tech Developers Connect to Connected Devices | Friedrich Lämmel, Thryve

By JESSICA DAMASSA, WTF HEALTH

Thryve has created a “connection point” for all different data sources that varies from other companies.Friedrich Lämmel explains the problem behind having just one data source and how the company makes it easier for companies make it more accessible for patients. Startups looking for a fast way to get access to hundreds of data points from top wearables, sensors, and tracking devices need look no further than Thryve. A single SDK point for accessing a bunch of health data, the company has taken the friction out of connecting to connected devices for developers in more ways than one. Friedrich Lämmel talks about all the ‘magic’ of Thryve and about winning the EC2VC competition at HIMSS/Health 2.0 Europe.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Can an App Help You Lose Weight? | André Heikius, Edevent

By JESSICA DAMASSA, WTF HEALTH

Can an app help you lose weight? Chairman & Medical Director for Edevent, Andre Heikius, thinks so. Billed as a ‘digital solution for obesity,’ Edevent is an app that offers professional weight loss advice 24-7 via a conversational algorithm that’s been designed to help people better understand the factors behind their weight gain. Are you eating too late at night? Are you an emotional eater? Find out how the app leverages evidence-based guidelines to help people make a difference on their waistlines.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Can You Treat IBS with an App? | Jossy Onwude of Bold Health

By JESSICA DAMASSA, WTF HEALTH

Bold Health hopes to help the millions that suffer with IBS (Irritable Bowel Syndrome) by providing a fully digital solution that is “as effective” as the drugs currently prescribed to treat the condition. Jossy Onwude, Chief Medical & Product Officer for Bold Health, explains how the company has created a digital therapeutic for delivering the NHS protocol for treating IBS and is currently working on clinical validation trials with some big-name partners.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Redefining STI & HIV Testing in the Netherlands | Erwin Fisser, Soa Aids Nederland

By JESSICA DAMASSA, WTF HEALTH

Soa Aids Nederland is a unique NGO in the Netherlands that is helping people get STI and HIV tests delivered directly to their homes. A government-funded NGO, the organization has created an extensive online questionnaire that is not only collecting data on sexual health, but also discreetly deploying testing kits to those who want a more private way to check for STIs. Erwin Fisser explains what’s next for the service — and the data that the extensive questionnaire is collecting.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

What’s the Difference Between ‘Digital Therapeutics’ & ‘Digital Drugs’? | Lina Behrens Flying Health

By JESSICA DAMASSA, WTF HEALTH

As a new crop of ‘digital therapeutics’ begins to redefine the Future of Pharma, health tech startups and their partners are starting to further refine how they explain (and clinically validate) the outcomes associated with their technologies. So, what’s the difference between a ‘digital drug’ and a ‘digital therapeutic’? Flying Health’s Director of Digital Drugs, Lina Behrens, explains…

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

What Oncology’s Figured Out About the EHR | Dr. Ed Kim of Atrium Health

By JESSICA DAMASSA, WTF HEALTH

Is there a silver bullet for making EHRs more useful to doctors? The Oncology team at Atrium Health thinks they’ve figured it out. From better integrating new info on FDA approved cancer treatments to just working with doctors and patients more intuitively, Dr. Ed Kim talks about how the underlying challenges health technologists need to address is figuring out what info is important to care delivery teams in the first place.

Filmed at Health Datapalooza in Washington DC, March 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Health in 2 Point 00, Episode 87 | Omada, Call9 & Politics

Today on Health in 2 Point 00, Jess and I are getting in the spirit of things with this week’s Democratic debate. In Episode 87, Jess asks me about Omada Health’s $73 million raise, bringing its total to $200 million, and about what happened with nursing home telehealth startup Call9 shutting down. We turn to politics with Trump telling HHS to have hospitals publish their price list—and it’s unclear that this is even going to make a difference—and to health care coverage in the Democratic debate. —Matthew Holt

Whole Genome Sequencing Heads for Consumers – Rodrigo Martinez of Veritas Genetics

By JESSICA DaMASSA, WTF HEALTH

DNA testing companies like 23andMe and Ancestry have made DNA testing mainstream, with adoption skyrocketing among consumers. Meanwhile, health tech startups like Veritas Genetics are starting to push the trend even further – from genotyping to whole genome sequencing. What’s the difference? Well, genotyping looks at less than half of 1% of your genome, while whole genome sequencing looks at over 99% of your genome.

Veritas is betting that consumers are ready for what’s revealed by looking at more than 6.4 billion letters of DNA and are promising that the value of that information will only get richer as time goes on and the science that makes sense of our genome achieves new breakthroughs.

In fact, Veritas is positioning their $999 test as “a resource for life” and Rodrigo Martinez, their Chief Marketing & Design Officer who I chat with here, shares a vision for the future that includes asking Alexa to scan your genome before taking medications or risking allergic reactions to foods.

This is fascinating proposition for the future of health (investors are jazzed too, having poured $50M into the company), but ethical questions abound. How do you make this information useful and actionable? How do you handle situations where major health issues are reveled? And what about data privacy? This is about as personal as personal health information can get. Rodrigo weighs in…

Registration

Forgotten Password?